Tools
Tools
Yoongthong, Worasuda, Hu, Shanlian, Whitty, Jennifer A. 
ORCID: https://orcid.org/0000-0002-5886-1933, Wibulpolprasert, Suwit, Sukantho, Kitti, Thienthawee, Wannisa, Han, Huixue and Scuffham, Paul A.
(2012)
National drug policies to local formulary decisions in Thailand, China, and Australia: Drug listing changes and opportunities.
Value in Health, 15 (1).
S126-S131.
ISSN 1098-3015
Abstract
This commentary is aimed at summarizing the second plenary session presented at the ISPOR 4th Asia-Pacific Conference held in 2010 and compare the issues on drug listing of Thailand, China, and Australia. These countries have substantially different demographic and economic characteristics and health-care financing structures and are in different phases of development of health technology assessment (HTA) (Table 1). Expenditure data shown in Table 1 for 2008 were converted at purchasing power parity to US dollars.
| Item Type: | Article |
|---|---|
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| Depositing User: | Pure Connector |
| Date Deposited: | 27 Apr 2016 14:00 |
| Last Modified: | 09 Nov 2022 15:31 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/58438 |
| DOI: | 10.1016/j.jval.2011.11.003 |
Actions (login required)
 |
View Item |